Terms: = Colorectal cancer AND KLK2, P20151, 3817, ENSG00000167751, MGC12201, hK2, KLK2A2 AND Prognosis
18 results:
1. OCT1 regulates the migration of colorectal cancer cells by acting on LDHA.
Li L; Chen W; Wu G; Sun P
Histol Histopathol; 2024 Jan; 39(1):67-77. PubMed ID: 37014018
[TBL] [Abstract] [Full Text] [Related]
2. NR3C2 inhibits the proliferation of colorectal cancer via regulating glucose metabolism and phosphorylating AMPK.
Liu H; Lei W; Li Z; Wang X; Zhou L
J Cell Mol Med; 2023 Apr; 27(8):1069-1082. PubMed ID: 36950803
[TBL] [Abstract] [Full Text] [Related]
3. NCAPD3 enhances Warburg effect through c-myc and E2F1 and promotes the occurrence and progression of colorectal cancer.
Jing Z; Liu Q; He X; Jia Z; Xu Z; Yang B; Liu P
J Exp Clin Cancer Res; 2022 Jun; 41(1):198. PubMed ID: 35689245
[TBL] [Abstract] [Full Text] [Related]
4. N
Li Y; He L; Wang Y; Tan Y; Zhang F
Bioengineered; 2022 May; 13(5):11923-11932. PubMed ID: 35546050
[TBL] [Abstract] [Full Text] [Related]
5. Activation of miR-500a-3p/CDK6 axis suppresses aerobic glycolysis and colorectal cancer progression.
Liu Y; Tang W; Ren L; Liu T; Yang M; Wei Y; Chen Y; Ji M; Chen G; Chang W; Xu J
J Transl Med; 2022 Mar; 20(1):106. PubMed ID: 35241106
[TBL] [Abstract] [Full Text] [Related]
6. Targeting hexokinase 2 increases the sensitivity of oxaliplatin by Twist1 in colorectal cancer.
Zhang B; Chan SH; Liu XQ; Shi YY; Dong ZX; Shao XR; Zheng LY; Mai ZY; Fang TL; Deng LZ; Zhou DS; Chen SN; Li M; Zhang XD
J Cell Mol Med; 2021 Sep; 25(18):8836-8849. PubMed ID: 34378321
[TBL] [Abstract] [Full Text] [Related]
7. LncRNA SNHG11 facilitates tumor metastasis by interacting with and stabilizing HIF-1α.
Xu L; Huan L; Guo T; Wu Y; Liu Y; Wang Q; Huang S; Xu Y; Liang L; He X
Oncogene; 2020 Nov; 39(46):7005-7018. PubMed ID: 33060856
[TBL] [Abstract] [Full Text] [Related]
8. Long noncoding RNA KCNQ1OT1 promotes colorectal carcinogenesis by enhancing aerobic glycolysis via hexokinase-2.
Chen C; Wei M; Wang C; Sun D; Liu P; Zhong X; Yu W
Aging (Albany NY); 2020 Jun; 12(12):11685-11697. PubMed ID: 32564010
[TBL] [Abstract] [Full Text] [Related]
9. FOXE1 represses cell proliferation and Warburg effect by inhibiting hk2 in colorectal cancer.
Dai W; Meng X; Mo S; Xiang W; Xu Y; Zhang L; Wang R; Li Q; Cai G
Cell Commun Signal; 2020 Jan; 18(1):7. PubMed ID: 31918722
[TBL] [Abstract] [Full Text] [Related]
10. Cdh1-mediated Skp2 degradation by dioscin reprogrammes aerobic glycolysis and inhibits colorectal cancer cells growth.
Zhou L; Yu X; Li M; Gong G; Liu W; Li T; Zuo H; Li W; Gao F; Liu H
EBioMedicine; 2020 Jan; 51():102570. PubMed ID: 31806563
[TBL] [Abstract] [Full Text] [Related]
11. Polo-like kinase 3 inhibits glucose metabolism in colorectal cancer by targeting HSP90/STAT3/hk2 signaling.
Ou B; Sun H; Zhao J; Xu Z; Liu Y; Feng H; Peng Z
J Exp Clin Cancer Res; 2019 Oct; 38(1):426. PubMed ID: 31655629
[TBL] [Abstract] [Full Text] [Related]
12. Chemokine (C-X-C motif) ligand 1 is associated with tumor progression and poor prognosis in patients with colorectal cancer.
Zhuo C; Wu X; Li J; Hu D; Jian J; Chen C; Zheng X; Yang C
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29784873
[TBL] [Abstract] [Full Text] [Related]
13. Poor prognosis of hexokinase 2 overexpression in solid tumors of digestive system: a meta-analysis.
Wu J; Hu L; Wu F; Zou L; He T
Oncotarget; 2017 May; 8(19):32332-32344. PubMed ID: 28415659
[TBL] [Abstract] [Full Text] [Related]
14. Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer.
Cai X; Ding H; Liu Y; Pan G; Li Q; Yang Z; Liu W
Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):119-127. PubMed ID: 28069585
[TBL] [Abstract] [Full Text] [Related]
15. Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer.
Graziano F; Ruzzo A; Giacomini E; Ricciardi T; Aprile G; Loupakis F; Lorenzini P; Ongaro E; Zoratto F; Catalano V; Sarti D; Rulli E; Cremolini C; De Nictolis M; De Maglio G; Falcone A; Fiorentini G; Magnani M
Pharmacogenomics J; 2017 Jun; 17(3):258-264. PubMed ID: 26927284
[TBL] [Abstract] [Full Text] [Related]
16. [Evaluation of Gene Expression of Hexokinases in colorectal cancer with the Use of Bioinformatics Methods].
Krasnov GS; Dmitriev AA; Sadtritdinova AF; Fedorova MS; Snezhkina AV; Melnikova NV; Poteryakhina AV; Nyushko KM; Belyakov MM; Kaprin AD; Zaretsky AR; Kudryavtseva AV
Biofizika; 2015; 60(6):1050-6. PubMed ID: 26855992
[TBL] [Abstract] [Full Text] [Related]
17. Combined evaluation of hexokinase 2 and phosphorylated pyruvate dehydrogenase-E1α in invasive front lesions of colorectal tumors predicts cancer metabolism and patient prognosis.
Hamabe A; Yamamoto H; Konno M; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Nishida N; Kawamoto K; Koseki J; Doki Y; Mori M; Ishii H
Cancer Sci; 2014 Sep; 105(9):1100-8. PubMed ID: 25060325
[TBL] [Abstract] [Full Text] [Related]
18. Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies.
Avgeris M; Mavridis K; Scorilas A
Biol Chem; 2010 May; 391(5):505-11. PubMed ID: 20302518
[TBL] [Abstract] [Full Text] [Related]
